Treatment in patients with chronic neuropathic pain in general practice

Neuropathic pain is a condition, which is caused by damage of nervous tissue, peripheral or central. Most cases of neuropathic pain are chronic and presented during months and years. This condition accompanies by significant lowering of patients` quality of life and severe limitations in social, occupational and/or other important areas of functioning. There are a variety of different types of neuropathic pain, including post-stroke pain, postherpetic neuralgia, fibromialgia, painful diabetic neuropathy and many other. Medicines that are effective against nociceptive pain, which arises from tissue damage (after a fall or in case of arthritic), are not helping in reducing of neuropathic pain. The most common used medications for this condition and current state of evidence in this field were described in this review.

Published: 23.12.2016

References:

• Blyth F.M., March L.M., Brnabic A.J.M. et al.(2001) Chronic pain in Australia: a prevalence study. Pain, 89: 127–134.
• Breivik H., Collet B., Vantafridda V. et al. (2006) Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur. J. Pain, 10: 287–333.
• Calandre E.P., Rico-Villademoros F., Slim M. (2016) Alpha2delta ligands, gabapentin, pregabalin and microgabalin: a review of their clinical pharmacology and therapeutic use. Exp. Rev. Neurotherap., June 29 [Epub. ahead of print].
• Chu H.-T., Chen C.-K., Tzeng N.-S. et al. (2016) Efficacy of pregabalin augmentation for refractory pain in late-life depression. ANZJP, Aug. 29 [Epub. ahead of print].
• Derry S., Cording M., Law S. et al. (2016) Pregabalin for pain in fibromyalgia in adults (Review). Cochrane Database of Systematic Reviews, 9: CD011790.
• Derry S., Wiffen P.J., Aldington D., Moore R.A. (2015) Nortpiptyline for neuropathic pain in adults. Cochrane Database of Systematic Reviews, 1: CD011209.
• Eccleston C., Hearn L., Williams A.C. (2015) Psychological therapies for the management of chronic neuropathic pain in adults. Cochrane Database of Systematic Reviews, 10: CD011259.
• Gallagher H.C., Gallager R.M., Butler M. et al. (2015) Venlafaxine for neuropathic pain in adults. Cochrane Database of Systematic Reviews, 8: CD011091.
• Gaskell H., Derry S., Stannard C., Moore R.A. (2016) Oxycodone for neuropathic pain in adults. Cochrane Database of Systematic Review, 7: CD010692.
• Gerardi M.C., Atzeni F., Batticcitto A. et al. (2016) The safety of pregabalin in the treatment of fibromyalgia. Expert Opinion and Drug Safety, Oct. 11 [Epub. ahead of print].
• Greater Manchester Medicines Management Group (2014) Neuropathic Pain Guideline (http://gmmmg.nhs.uk/docs/guidance/GMMMG%20Neuropathic%20Pain%20Guidance%20March%202014.pdf).
• Hetta D.F., Mohamed M.A., Mohammad M.F. (2016) Analgetic efficacy of pregabalin in acute postmastectomy pain: placebo controlled dose ranging study. J. Clin. Anest., 34: 303–309.
• Hsieh J.-C., Stahle-Backdahl M., Hagermark O. et al. (1995) Traumatic nociceptive pain activates the hypothalamus and the periaqueductal gray: a positron emission tomography study. Pain, 64: 303–314.
• Kumar A., Bhoi S.K., Kalita J., Misra U.K. (2015) Central Post Stroke Pain Can Occur With Normal Sensation. Clin. J. Pain, Dec. 24 [Epub. ahead of print].
• Markman J.D., Jensen T.S., Semel D. et al. (2016) Effects of pregabalin in patients with neuropathic pain previously treated with gabapentin: A pooled analysis of parallel-group, randomized, placebo-controlled clinical trials. Pain Pract., Sep. 9 [Epub. ahead of print].
• Merskey H., Addison R.G., Beric A. et al. (2002) Classification of chronic pain. IASP, Seattle (http://www.iasp-pain.org/files/Content/ContentFolders/Publications2/FreeBooks/Classification-of-Chronic-Pain.pdf).
• Mico J.A., Ardid D., Berrocoso E. et al. (2006) Antidepressants and pain. TRENDS in Pharmacological Sciences, 27(7): 348–353.
• Moore R.A., Chi C.-C., Wiffen P.J. et al. (2015) Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database of Systematic Reviews, 10: CD010902.
• Moulin D., Boulanger A., Clark A.J. et al. (2014) Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Res. Manag., 19(6): 328–335.
• NICE (2014) Neuropathic pain in adults: pharmacological management in non-specialist settings. Clinical guideline [CG173] (https://www.nice.org.uk/guidance/CG173/chapter/1-Recommendations #treatment).
• Ogawa S., Arakawa A., Hayakawa K., Youshiyama T. (2016) Pregabalin for Neuropathic Pain: Why Benefits Could be Expected for Multiple Pain Conditions. Clin. Drug. Invesig, 36: 877–888.
• Parsons B., Li C. (2016) The efficacy of pregabalin in patients with moderate and severe pain due to diabetic peripheral neuropathy. Curr. Med. Res. Opin., 32(5): 929–937.
• Raskin P., Huffman C., Yurkewicz L. et al. (2016) Pregabalin in Patinets with Painful Diabetic Peripheral Neuropathy Using an NSAID for Other Pain Conditions: A Double-Blind Crossover Study. Clin. J. Pain, 32: 203–210.
• Robertson K., Marshman L.A.G., Plummer D. (2015) Pregabalin and gabapentin for the treatment of sciatica. J. Clin. Neuroscience [Epub. ahead of print].
• WHO Steering Group on Pain Guidelines (2008) Scoping Document for WHO Treatment Guideline on Non-malignant Pain in Adults (http://www.who.int/medicines/areas/quality_safety/Scoping_WHOGuide_non-malignant_pain_adults.pdf?ua=1).
• Zarei M., Najafi A., Mansouri P. et al. (2016) Management of postoperative pain after Lumbar surgery — pregabalin for one day and 14 days — a randomized, triple-blinded, placebo-controlled study. Clin. Neurol. Neurosurgery, Oct. 12 [Epub. ahead of print].